Tax expression is associated with decreased cellular motility. by Saumya Ramanayake (7879091)

Subjects:

Distribution of miRs with a greater than two fold-change. by Stephanie L. Samani (17896610)

Subjects:

Fig 5 - by Duyan Geng (12072181)

Subjects:

Characteristics of patients with AKI diagnosed using eKDIGO only by the decrease in sCr (deKDIGO) and no AKI. by Marina Wainstein (12437091)

Growth on stiff substrate results in mild lifespan extension but a decrease in organismal health. by Maria Oorloff (19658113)

Patients with high baseline gut richness and diversity have significantly greater decreases in diversity over time. by Molly B. El Alam (10231830)

Foldases and holdases each decrease the level of unfolded protein. by Adam MR de Graff (9767829)

Detailed meta–analyses in untreated hypothyroid patients compared with controls for each HRV parameters: RR intervals, SDNN, RMSSD, pNN50, TP, LF, HF, LF/HF. by Valentin Brusseau (12769704)

Lower insular perfusion in patients with hypoactive delirium compared with the non-DAT group. by Masashi Takeuchi (1930312)

Subjects:

Multifactorial nature of DAT and possible involvement of preoperative CBF in the insula. by Masashi Takeuchi (1930312)

Subjects:

Lower insular perfusion in the DAT group compared with the non-DAT group. by Masashi Takeuchi (1930312)

Subjects:

Results of multivariable logistic regression analyses with an addition of CBF in the insula to classical indicators. by Masashi Takeuchi (1930312)

Subjects:

Baseline patient characteristics. by Masashi Takeuchi (1930312)

Subjects:

Flow chart of patient enrollment in the present study. by Masashi Takeuchi (1930312)

Subjects:

Intraoperative and postoperative variables. by Masashi Takeuchi (1930312)

Subjects:

Preoperative drug use. by Masashi Takeuchi (1930312)

Subjects:

Results of univariable regression analyses with delirium as an outcome. by Masashi Takeuchi (1930312)

Subjects:

Characteristics of patients with AKI diagnosed using KDIGO definition versus patients diagnosed with AKI by eKDIGO only by the decrease in sCr (deKDIGO). by Marina Wainstein (12437091)

Antibody IC₅₀ (or pIC₅₀) and maximum neutralization of D614G and BA.1 pseudoviruses bearing different glycosylation and SARS-CoV-2 VLPs. by Sabrina Lusvarghi (2329267)

Proportion of round 1 simulated product availability estimates with bias of greater than 5%. by Brett Keller (4326340)

“…Bias greater than 5% in either direction, and mean absolute bias, tend to decrease as sample size per pseudo-EA is increased, with the largest reduction in bias occuring when sample size increased from 3 to 6 outlets per pseudo-EA.…”